跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
KUVAN
Authorized
STANDARD
KUVAN
Biomarin International Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cb6b3a5f4b6fccaa
Company
Biomarin International Limited
Type
Standard
Approval Details
Approval Id
cb6b3a5f4b6fccaa
Drug Approval Canada Name
KUVAN
Product Name
KUVAN
Status
Marketed
Status Date
2019-12-05
Original Market Date
2019-12-05
Din
02482215
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:92.00
Atc Original
A16AX07 SAPROPTERIN
Atc Name
a 16 ax 07
Aig Number
0152714002
Company Name
Biomarin International Limited
Company Address
Shanbally, Ringaskiddy, Cork, Ireland, P43R298
Company Detail Path
/organization/biomarin-international-limited
Company Information
Pharmaceutical Company Name
Biomarin International Limited
Country Name
Australia
Active Ingredients
SAPROPTERIN DIHYDROCHLORIDE
500 MG / SACHET
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cb6b3a5f4b6fccaa
Type
Standard
Back to Health Canada Approvals
KUVAN - Health Canada Drug Approval Details